Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 162.33M P/E - EPS this Y -5.60% Ern Qtrly Grth -
Income -101.39M Forward P/E -2.62 EPS next Y 44.40% 50D Avg Chg 1.00%
Sales 1.82M PEG 0.11 EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 1.58 EPS next 5Y -1.60% 52W High Chg -53.00%
Recommedations 2.80 Quick Ratio 3.50 Shares Outstanding 65.46M 52W Low Chg 76.00%
Insider Own 0.66% ROA -42.36% Shares Float 41.71M Beta -0.01
Inst Own 59.26% ROE -156.52% Shares Shorted/Prior 3.14M/4.15M Price 3.28
Gross Margin - Profit Margin - Avg. Volume 191,390 Target Price 1.25
Oper. Margin -2,977.43% Earnings Date Nov 5 Volume 58,772 Change 0.00%
About Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Lyra Therapeutics, Inc. News
11/14/24 Lyra Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/12/24 Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates
11/12/24 Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/15/24 Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis
09/27/24 Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
08/22/24 Lyra Therapeutics Insiders Still US$66k Away From Original Investment Value
08/14/24 Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Tops Revenue Estimates
08/14/24 Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
07/15/24 Lyra Therapeutics, Inc. (LYRA): A Good Penny Stock to Buy For Under $1?
08:14 AM Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
05/07/24 Target upgraded, CVS downgraded: Wall Street's top analyst calls
05/06/24 Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
05/02/24 Lyra Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
04/30/24 Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
04/30/24 Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/26/24 Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/28/24 Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
03/26/24 Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well
03/25/24 Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
03/23/24 Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
LYRA Chatroom

User Image LoveRetailFroth Posted - 1 hour ago

$MIRA My laggards come on let’s go! $AIEV $LYRA

User Image LoveRetailFroth Posted - 1 hour ago

$MIRA My laggards come on. $AIEV $LYRA

User Image Gunter0711 Posted - 3 hours ago

$LYRA and the yo-yo continues. I wonder how much of these gains do we hold.

User Image pablo4 Posted - 3 hours ago

$LYRA once the funds are done selling, say goodbye to the below .20 shares. JMO

User Image Wristburn Posted - 18 hours ago

$LYRA https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

User Image RFCAPITAL Posted - 1 day ago

$LYRA 1 more dip to $0.16

User Image RETAlerts Posted - 1 day ago

mpressive progress for $LYRA at 0.207, now up 10% since we first mentioned it. Keep watching closely as it navigates through key resistance levels. (15 minute delay)

User Image RETAlerts Posted - 1 day ago

solid 10% gain for $LYRA at 0.201 since it first appeared on our radar. Keep tabs on the RSI and MACD indicators for clues on whether this momentum is sustainable. (15 minute delay)

User Image Prof_Amen1 Posted - 1 day ago

$LYRA In fact, someone had the same thought as me

User Image RETAlerts Posted - 1 day ago

mpressive progress for $LYRA at 0.194, now up 10% since we first mentioned it. Keep watching closely as it navigates through key resistance levels. (15 minute delay)

User Image gamma34 Posted - 2 days ago

$LYRA How much cash and debt does $LYRA have? Why do some sources say they have no debt while yahoo finance says 35M debt?

User Image Kukc Posted - 2 days ago

$LYRA opened a small position

User Image _Stockarma Posted - 2 days ago

$LYRA whats going on here?

User Image StockCrushing Posted - 2 days ago

$LYRA $LAES $BTM $MGX $HUBC 👀 My position at the moment may wake up to $LAES up Big like the potential 💸💸💸

User Image RFCAPITAL Posted - 2 days ago

$LYRA maybe $0.14 is golden number ..!! Let’s wait for it !!

User Image Prof_Amen1 Posted - 3 days ago

$LYRA completely no sense... At this point either they know they won't find any partners or they want to get everyone out to make a violent movement of 200/300% with good news... I keep holding on I don't go out

User Image RFCAPITAL Posted - 3 days ago

$LYRA what’s happening boys

User Image CainboolJ Posted - 3 days ago

😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $LYRA $AIM

User Image pablo4 Posted - 5 days ago

$LYRA funds have dumped at any price over recent days. Schedule 13 filings show it. The latest 10q filing, in the Summary of Risks section, mentions the company may not be able to find a strategic deal. That implies to me they are looking. Consider, the Enlighten 1 trial failed efficacy back in May. Before you find a strategic deal, you have to show your asset has some redeeming value. Since May, more has been learned on LYR-210 that may show redeeming value. LYR-210 has shown it's safe to use (now that the extension is done); also, LYR-210 helped those with CRS who had nasal polyps. Now, there's at least something to dangle to a suitor....plus another Enlighten phase 3 trial yet to report. This is the time to "deal," IMO. And, IMO, one can bet if they can swing a deal, it will be better than .30/share, IMO.

User Image AKBIGD Posted - 6 days ago

$LYRA heavy Orders coming in

User Image jayle1 Posted - 6 days ago

$LYRA told y’all! There is no win for investors even if they can get it through backdoor. They said they will dump more shares no matter what’ll happen to their phase 3 drugs.

User Image wolfhowll Posted - 6 days ago

$LYRA wtf is happening with this stock ??

User Image pablo4 Posted - 6 days ago

$LYRA wow; I wish I could be just entering here.....my average is down in mid .20s now after picking some up this morning to average down. I think this level is going to make someone a good return.....just programmed fund dumping. The problem is knowing exactly when it's over...but I think it'll rebound fast when it's over. Yes, I wish I could be entering now. JMO

User Image Suffix Posted - 6 days ago

$LYRA I'm in again, $.1813 avg. I'm all in for December but slowly. Good luck all

User Image Prof_Amen1 Posted - 6 days ago

$LYRA I'm with you

User Image gbuster57 Posted - 6 days ago

$LYRA Espr Two approved drugs will be a money machine soon if it doesn’t get bought out while we wait here

User Image zrosiez Posted - 6 days ago

$LYRA and that’s why I avoid biotech stocks like this one. I’m expecting an RS soon.

User Image Chuckyboss1 Posted - 6 days ago

$LYRA as Pablo was saying this is window dressing big boys sell there losers to look like winners 2024-11-14 13G/A Samsara BioCapital, L.P. 2,780,261 3,281,766 18.04 4.98 -11.07 2024-11-14 13G/A Venrock Healthcare Capital Partners II, L.P. 5,553,552 1,204,094 -78.32 1.80 -82.00 2024-11-14 13G/A Vestal Point Capital, LP 3,000,000 0 -100.00 0.00 -100.00 2024-11-14 13G/A Point72 Asset Management, L.P. 3,030,283 0 -100.00 0.00 -100.00 2024-08-15 13D/A PERCEPTIVE ADVISORS LLC 12,757,563 12,757,562 -0.00 19.50 -19.75 2024-02-14 13G/A PURA VIDA INVESTMENTS, LLC 2,157,298 1,613,844 -25.19 3.06 -54.87 2024-02-14 13G/A Nantahala Capital Management, LLC 2,220,830 4,752,324 113.99 8.90 27.14 2024-02-14 13G/A CITADEL ADVISORS LLC 7.90 33.90 2023-11-24 13G RTW INVESTMENTS, LP 5,175,832 13.40

User Image LiquidatingValue Posted - 6 days ago

$LYRA Over 10 mil volume in the past 2 days. Vestal Point Capital closed their 3 mil position. Yeah, as Pablo was saying, definitely funds had enough and getting rid of shares, no matter the price.

User Image HitItHard3585 Posted - 6 days ago

$LYRA Daily is similar to XFOR? Possible pop off of 52 week low?

Analyst Ratings
Cantor Fitzgerald Overweight Aug 15, 24
HC Wainwright & Co. Neutral Aug 15, 24
Cantor Fitzgerald Overweight Jun 20, 24
HC Wainwright & Co. Neutral May 7, 24
Jefferies Hold May 7, 24
BTIG Neutral May 6, 24
HC Wainwright & Co. Buy May 1, 24
B of A Securities Buy Mar 25, 24
HC Wainwright & Co. Buy Mar 22, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Waksal Harlan Executive Chair Executive Chair Nov 10 Buy 2.9638 25,000 74,095 261,966 11/13/23
MERRIFIELD C ANN Director Director May 13 Buy 4.91 3,828 18,795 7,328 05/17/22
PERCEPTIVE ADVISORS LLC Director Director Apr 12 Buy 4.22 5,924,170 24,999,997 7,858,285 04/14/22
Waksal Harlan Executive Chair Executive Chair Apr 12 Buy 4.22 236,966 999,997 236,966 04/13/22